特里卡图精油作为芳香疗法剂的协同潜力:化学和机械审查
Dewa Ayu Ika Pramitha1,2, Tati Herlina1, Iman Permana Maksum1
1Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Jatinangor, 45363, Indonesia.
Drug design, development and therapy
|August 11, 2025
概括
来自三种植物的特里卡图精油 (TREO) 显示了芳香疗法的潜力. 它的化合物通过与大脑受体相互作用,提供抗氧化,抗炎和神经保护的益处.
科学领域:
- 药理学和神经科学 药理学和神经科学
- 自然产品化学 自然产品化学
- 芳香疗法是一种芳香疗法.
背景情况:
- 特里卡图精油 (TREO) 是 Piper nigrum,Piper retrofractum 和 Zingiber officinale var. 的混合物. 鲁布鲁姆 鲁布鲁姆 鲁布鲁姆
- TREO含有具有潜在治疗应用的生物活性化合物.
研究的目的:
- 审查TREO的抗氧化,抗炎,抗焦虑和神经保护性质.
- 探索支持这些生物活动的科学证据.
- 评估TREO作为吸入芳香疗法剂的潜力.
主要方法:
- 分析TREO的化学组成.
- 对TREO成分的生物活性进行科学文献的审查.
- 研究受TREO影响的分子标和途径.
主要成果:
- 像β-Caryophyllene和Eucalyptol这样的关键化合物与GABA,CB2和血清素受体相互作用.
- 在减少氧化应激和炎症 (TNF-α,IL-1β) 方面,TREO表现出协同作用.
- TREO通过BDNF途径促进神经可塑性,并调节神经系统.
结论:
- TREO具有显著的抗氧化,抗炎和神经保护性质.
- TREO化合物的协同作用增强了其治疗潜力.
- 通过芳香疗法,TREO显示出通过芳香疗法促进身体和精神健康的前景.
相关概念视频
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Aromatic Compounds: Overview
11.4K
In general, the term ‘aromatic’ indicates a pleasant smell or fragrance from fresh flowers, freshly prepared coffee, etc. In the early history of organic chemistry, many benzene derivatives were isolated from the pleasant odor oils of the plants. For example, vanillin was isolated from the oil of vanilla, methyl salicylate from the oil of wintergreen, and cinnamaldehyde from the oil of cinnamon. They all had a pleasant odor; hence the name aromatic was given.
In 1825, Faraday...
In 1825, Faraday...
11.4K
Agonism and Antagonism: Quantification
566
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
566
Aromatic Hydrocarbon Cations: Structural Overview
3.0K
Cycloheptatriene is a neutral monocyclic unsaturated hydrocarbon that consists of an odd number of carbon atoms and an intervening sp3 carbon in the ring. The three double bonds in the ring correspond to 6 π electrons, which is a Huckel number, and therefore satisfies the criteria of 4n + 2 π electrons. However, the intervening sp3 carbon disrupts the continuous overlap of p orbitals. As a result, cycloheptatriene is not aromatic.
Removing one hydrogen from the intervening CH2 group...
Removing one hydrogen from the intervening CH2 group...
3.0K
Adrenergic Agonists: Direct-Acting Agents
1.7K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.7K
Therapeutic Index
5.1K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.1K


